Two federal agencies — the US Food and Drug Administration and the Centers for Medicare & Medicaid Services — with oversight of genetic tests are looking into the regulation of direct-to-consumer genetic testing, agency officials said during an online meeting hosted by the American Association of Clinical Chemistry last week.

Judy Yost, CMS' laboratory divisions director, said during the AACC meeting that the agency is "monitoring" DTC labs offering genetic testing to ensure compliance where the Clinical Laboratory Improvement Amendments are applicable.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

At her blog, Sally Rockey dives into National Institutes of Health funding data.